Granules India Launches Pharma Innovation Hubs at IIT Hyderabad

Granules India has significantly boosted its pharmaceutical innovation capabilities with the inauguration of two advanced Centres of Excellence at the Technology Research Park of IIT Hyderabad. These state-of-the-art facilities, established on Monday, December 1, 2025, are poised to drive significant advancements in the pharmaceutical sector.

The Ascelis Center of Excellence for Peptide Development and Characterisation, operating under Granules' CDMO arm, Ascelis Peptides, will spearhead the development of peptides for cosmetic, therapeutic, and pharmaceutical uses. This facility marks Ascelis' first development and characterisation center in India, equipped with advanced analytical tools to characterize peptide structures and processes, aiming to reduce reliance on external partners.

Complementing this is the Granules Center of Excellence for Particle Engineering, dedicated to advancing polymorph research, material science, and novel drug delivery systems, including amorphous solid dispersions. This dedicated platform is designed to secure first-to-file opportunities, enhance formulation performance, and develop proprietary technologies for regulated markets, thereby elevating global competitiveness.